Hypoglycemia due to adrenal suppression secondary to high‐dose nebulized corticosteroid | Zendy

Dunlop K.A. | Zendy; Carson D.J. | Zendy; Shields M.D. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Hypoglycemia due to adrenal suppression secondary to high‐dose nebulized corticosteroid

Author(s) -

Dunlop K.A.,

Carson D.J.,

Shields M.D.

Publication year - 2002

Publication title -

pediatric pulmonology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.866

H-Index - 106

eISSN - 1099-0496

pISSN - 8755-6863

DOI - 10.1002/ppul.10132

Subject(s) - medicine , adrenal crisis , budesonide , corticosteroid , adrenal insufficiency , hypoglycemia , anesthesia , asthma , inhaled corticosteroids , pediatrics , endocrinology , diabetes mellitus

High‐dose inhaled corticosteroids, greater than 400 mcg per day of beclomethasone dipropionate or equivalent, can cause adrenal insufficiency, but a hypoglycemic crisis has not been reported with the use of nebulized corticosteroids. We describe a 21‐month‐old asthmatic boy who had a hypoglycemic seizure during a proven acute adrenal crisis secondary to high‐dose nebulized budesonide treatment. Pediatr Pulmonol. 2002; 34:85–86. © 2002 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research